About the journal
RevisX’s mission statement
RevisX is committed to advancing reproducible, rigorous, and translational biomedical and clinical research while addressing key challenges in modern scientific publishing.
The journal supports reproducibility-focused research through the publication of replication and validation studies, translational failure analyses, methodological verification studies, negative results, protocol reproducibility reports, and computational reproducibility research.
RevisX also aims to improve scientific publishing workflows by supporting efficient and transparent editorial processes that reduce delays between manuscript submission and reviewed publication.
The journal further provides an interdisciplinary platform for research integrating biomedical sciences, translational medicine, artificial intelligence, emerging healthcare technologies, and clinical applications.
Aims & Scope
RevisX is a peer-reviewed interdisciplinary journal focused on reproducible, rigorous, and translational biomedical and clinical research. The journal aims to address major challenges in modern scientific publishing, including reproducibility limitations, translational gaps, interdisciplinary fragmentation, and inefficiencies in traditional publishing workflows.
RevisX publishes research spanning biomedical sciences, translational medicine, clinical
research, artificial intelligence in healthcare, and emerging medical technologies, with
emphasis on methodological rigor, validation, transparency, and real-world healthcare relevance.
The journal particularly welcomes:
- Replication and validation studies
- Replication failure analyses
- Methodological verification studies
- Protocol reproducibility research
- Implementation-focused research
- Interdisciplinary biomedical systems research.
Areas of interest include, but are not limited to:
- Immunology, immune engineering and immunotherapies
- Genetics, genomics, and molecular biology
- Neuroscience and neurotechnology
- Pharmacology and translational therapeutics
- Regenerative medicine and stem cell research
- Precision and personalized medicine
- Experimental and translational medicine
- Oncology, neurology, cardiovascular medicine, endocrinology, and infectious diseases
- Clinical trials, validation studies, and real-world implementation research
What We Publish
RevisX accepts original research articles, clinical studies, translational investigations, systematic reviews, methodological papers, validation studies, and reproducibility-focused scientific reports For more details about content type, please check Content type.
